Cascade Pharmaceuticals is a clinical-stage biopharmaceutical company established on December 26, 2017. Focused on addressing unmet medical needs in metabolic diseases and inflammation, the company specializes in the discovery, development, and commercialization of innovative drugs targeting nuclear receptors and G protein-coupled receptors (GPCRs). Guided by its mission, “Curing diseases, enabling healthier lives,” Cascade strives to be a global leader in next-generation drug development.

With over 30 years of expertise in innovative drug development, Cascade is a pioneer in utilizing protein crystal structures for drug design. Its core team possesses end-to-end experience in pharmaceutical R&D and commercialization. Backed by a strong culture of innovation, the company has established a comprehensive preclinical research platform, including SPF-grade animal facilities, drug design and synthesis systems, and platforms for drug metabolism, pharmacology, and efficacy evaluation.